优化多发性骨髓瘤临床试验:研究方向,解决局限性和改进策略
M S Ebraheem1, M Gertz2, Hira Mian1
1Department of Oncology, McMaster University, Hamilton, ON, Canada.
Leukemia & lymphoma
|October 3, 2024
概括
针对多发性骨髓瘤 (MM) 的随机对照试验 (RCT) 在患者纳入和结果测量方面面临挑战. 本综述建议改进试验设计和整合现实世界的证据,以提高治疗指南和患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 临床试验 临床试验
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 治疗已取得进展,但将随机对照试验 (RCT) 发现转化为实践仍然具有挑战性.
- 目前的MM RCT设计往往排除了可能受益最多的患者群体,并且可能无法完全捕捉患者相关的结果.
- 需要弥合临床试验证据和多发性骨髓瘤患者的现实世界护理之间的差距.
研究的目的:
- 审查多发性骨髓瘤随机对照试验的当前情况.
- 确定MM临床试验的概括性和后勤执行方面的挑战.
- 为改善MM试验设计和整合现实世界的证据提出解决方案.
主要方法:
- 目前多发性骨髓瘤随机对照试验的文献综述.
- 分析试验设计,患者选择和结果衡量的常见局限性.
- 探索提高试验概括性的策略,并纳入真实世界的数据.
主要成果:
- 在MMRCT中,患者包容性往往受到限制,可能会排除弱势或特定的患者亚组.
- 在MM RCT中的主要结果可能无法全面评估患者报告的益处或生活质量.
- 后勤障碍可能会阻碍试验结果的成功实施和广泛采用.
结论:
- 提高MM RCT的概括性需要解决患者选择标准和结果相关性.
- 整合现实世界的证据可以补充RCT数据,提供对治疗有效性的更全面的看法.
- 完善的试验策略对于更新多发性骨髓瘤治疗指南和改善所有患者的护理至关重要.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...